TP53 and malignant colon neoplasm: Moreover, given that p53 mutations are common in colon cancer (Kameyama et al., 2018) and γ-catenin interacts directly with both wild type and mutant p53, a thorough investigation into the role of these interactions in the context of intestinal homeostasis and disease is warranted.